Iomeron (Iomeprol)

Iomeprol contains high‑density iodine atoms that absorb X‑rays more strongly than surrounding tissues. When injected, the iodine distributes in the vascular, intra‑articular or intrathecal compartments, creating a radiopaque contrast that highlights anatomical structures during imaging procedures.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function and the route of administration. Only a qualified healthcare professional should set the appropriate amount.

The safety of Iomeron in pregnancy and lactation has not been established. It should be used only if the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and after careful consideration by the treating physician.

To place an order, submit an enquiry on the Iomeron product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Iomeron is a non‑ionic, low‑osmolality iodinated contrast medium, offering a favorable safety profile compared with high‑osmolality agents. It provides high image quality while reducing the incidence of discomfort and adverse reactions relative to older ionic contrast media.

Iomeron should be stored at ambient temperature, protected from direct sunlight, moisture and extreme temperatures. Keep the vial in its original packaging until use and avoid shaking the solution vigorously to maintain its stability.

Iomeron is supplied as a sterile solution for injection and is administered by a qualified healthcare professional via intra‑arterial, intra‑articular or intrathecal routes, depending on the imaging study. The injection is performed under aseptic conditions using appropriate catheters or needles.

The most serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to acute renal impairment, and rare neurological events like seizures. Immediate medical attention is required if any of these symptoms occur.

Iomeron should be avoided in patients with a known hypersensitivity to iodine‑based contrast agents, those with severe uncontrolled asthma, or individuals with significant renal impairment where alternative imaging methods are feasible. The prescribing clinician must evaluate each case individually.